BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23475489)

  • 1. [Bacterial type I topoisomerases - biological function and potential use as targets for antibiotic treatments].
    Szafran M; Zakrzewska-Czerwińska J; Jakimowicz D
    Postepy Hig Med Dosw (Online); 2013 Mar; 67():130-42. PubMed ID: 23475489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.
    Tse-Dinh YC
    Infect Disord Drug Targets; 2007 Mar; 7(1):3-9. PubMed ID: 17346206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA Topoisomerases as Targets for Antibacterial Agents.
    Hiasa H
    Methods Mol Biol; 2018; 1703():47-62. PubMed ID: 29177732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I DNA Topoisomerases.
    Capranico G; Marinello J; Chillemi G
    J Med Chem; 2017 Mar; 60(6):2169-2192. PubMed ID: 28072526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and mechanism of action of type IA DNA topoisomerases.
    Bugreev DV; Nevinsky GA
    Biochemistry (Mosc); 2009 Dec; 74(13):1467-81. PubMed ID: 20210704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacterial type II topoisomerases as targets for antibacterial drugs].
    Pietrusiński M; Staczek P
    Postepy Biochem; 2006; 52(3):271-82. PubMed ID: 17201062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics.
    Tse-Dinh YC
    Future Med Chem; 2015; 7(4):459-71. PubMed ID: 25875873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA topoisomerases as targets for anticancer drugs.
    Topcu Z
    J Clin Pharm Ther; 2001 Dec; 26(6):405-16. PubMed ID: 11722677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA topoisomerase I from mycobacteria--a potential drug target.
    Nagaraja V; Sikder D; Jain P
    Curr Pharm Des; 2002; 8(22):1995-2007. PubMed ID: 12171525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DNA supercoiling and topoisomerases in Escherichia coli].
    Gómez-Eichelmann MC; Camacho-Carranza R
    Rev Latinoam Microbiol; 1995; 37(3):291-304. PubMed ID: 8850348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial thiol oxidoreductases - from basic research to new antibacterial strategies.
    Bocian-Ostrzycka KM; Grzeszczuk MJ; Banaś AM; Jagusztyn-Krynicka EK
    Appl Microbiol Biotechnol; 2017 May; 101(10):3977-3989. PubMed ID: 28409380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors.
    Yu X; Zhang M; Annamalai T; Bansod P; Narula G; Tse-Dinh YC; Sun D
    Eur J Med Chem; 2017 Jan; 125():515-527. PubMed ID: 27689733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting bacterial topoisomerases: how to counter mechanisms of resistance.
    Tse-Dinh YC
    Future Med Chem; 2016 Jun; 8(10):1085-100. PubMed ID: 27285067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type IA DNA Topoisomerases: A Universal Core and Multiple Activities.
    Garnier F; Debat H; Nadal M
    Methods Mol Biol; 2018; 1703():1-20. PubMed ID: 29177730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Poisons of DNA topoisomerases I and II].
    Charcosset JY; Soues S; Laval F
    Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-component signal transduction as potential drug targets in pathogenic bacteria.
    Gotoh Y; Eguchi Y; Watanabe T; Okamoto S; Doi A; Utsumi R
    Curr Opin Microbiol; 2010 Apr; 13(2):232-9. PubMed ID: 20138000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The many lives of type IA topoisomerases.
    Bizard AH; Hickson ID
    J Biol Chem; 2020 May; 295(20):7138-7153. PubMed ID: 32277049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Coordinated Positive Regulation of Topoisomerase Genes Maintains Topological Homeostasis in Streptomyces coelicolor.
    Szafran MJ; Gongerowska M; Gutkowski P; Zakrzewska-Czerwińska J; Jakimowicz D
    J Bacteriol; 2016 Nov; 198(21):3016-3028. PubMed ID: 27551021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel bacterial topoisomerase I inhibitors by use of in silico docking and in vitro assays.
    Sandhaus S; Chapagain PP; Tse-Dinh YC
    Sci Rep; 2018 Jan; 8(1):1437. PubMed ID: 29362471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence as a target for antimicrobial chemotherapy.
    Alksne LE
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1149-59. PubMed ID: 12150708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.